Dr. Devaraj Reddy Joins the Sami-Sabinsa Group as Chief Operating Officer
The Sami-Sabinsa Group, a global leader in the nutraceutical and cosmeceutical industries, is delighted to announce the addition of Dr. Devaraj Reddy to the management team as Chief Operating Officer.…
Read MoreSabinsa Founder Dr. Muhammed Majeed Honored with Times Business Awards Lifetime Achievement Award (Posthumous)
Sami-Sabinsa founder, the late Dr. Muhammed Majeed, was honored with the Times Business Awards Lifetime Achievement Award (Posthumous) for his exemplary contributions to Nutraceuticals and Cosmeceuticals, and Philanthropy in a ceremony in Bengaluru, India on June 21, 2024. Dr. Anju Majeed, Sami-Sabinsa Group Executive Chairperson, and Mr. Shaheen Majeed, Global Managing Director & CEO of Sami-Sabinsa Group, received the award honoring their father.…
Read MoreSami-Sabinsa Group Mourns Passing of Dr. Nagabhushanam Kalyanam Ph.D., President R&D
Dr. Anju Majeed, Sami-Sabinsa Group Executive Chairperson, Shaheen Majeed, Sami-Sabinsa Group Global Managing Director & Chief Executive Officer, and the entire Sami-Sabinsa Group family mourns the sudden passing of President R&D Nagabhushanam Kalyanam, Ph.D. at age 74. Dr. Kalyanam was a dedicated scientific advisor to Dr. Muhammed Majeed, Founder and Chairman, of Sami-Sabinsa Group in the development of the company s various high-quality ingredients until Dr. Majeed s passing in March.…
Read MoreSami-Sabinsa Group Elevates Dr. Anju Majeed to Group Executive Chairperson, Appoints Mr. Shaheen Majeed as the new Global Managing Director & CEO
Sabinsa, the multi national health science company founded by the late Dr. Muhammed Majeed 36 years ago, announces Dr. Anju Majeed as Sami-Sabinsa Group Executive Chairperson, assuming the role her father held until his death on March 13, 2024. The company also announced Shaheen Majeed as Global Managing Director & CEO.…
Read MoreDr. Muhammed Majeed (September 25, 1948 March 13, 2024) Founder and Chairman, Sami-Sabinsa Group
As a researcher, scientist, entrepreneur, and business leader, Dr. Majeed pioneered the development of standardized herbal extracts from India s Ayurvedic plants and created a global market for them. He founded and, for 36 years, led the Sami-Sabinsa Group as it became a leading multinational health & life sciences company.…
Read MoreSami-Sabinsa Group Named to Top 10 Pharma Laboratories by India Pharma Outlook
The Sami-Sabinsa Group has been named one of the Top 10 Pharma Laboratories of 2022 by India Pharma Outlook in honor of the company�s exceptional diligence and inimitable approach to fulfilling customer requirements.…
Read MoreSabinsa to Showcase Innovative Nutraceutical and Cosmeceutical Ingredients at Bio Asia-Taiwan Exhibition
Sabinsa will exhibit at Asia Healthcare & Medical Cosmetology Expo, part of Bio Asia-Taiwan Exhibition, to be held from 28th - 31st July, 2022, in Taipei, Taiwan. The show brings together the Nutraceutical and Cosmetology industry, including materials, manufacturing, OEM/ODM, packaging, and high-end products.…
Read MoreSami-Sabinsa Founder Expresses Sadness on Passing of CEO V.G. Nair
Sami-Sabinsa Group�s founder, Chairman, and Managing Director Dr. Muhammed Majeed is sad to announce that Mr. V.G. Nair, Director and CEO of the Sami-Sabinsa Group, passed away on July 6 due to complications from Covid-19.…
Read MoreSabinsa to Showcase Innovative Ingredients at Nutraceuticals Europe Summit & Expo (Spain)
Sabinsa Europe will showcase the company�s ingredients conceived by modern science drawn from traditional Ayurvedic knowledge at Nutraceuticals Europe Summit & Expo June 15 � 16, 2022. The event, which combines the analysis of trends, scientific innovation, and training through academic content, will be held at the Barcelona international Convention Center in Barcelona, Spain.…
Read MoreSabinsa to Highlight Research-supported Ingredients, Showcase New Beverage Concepts at IFIA Japan 2022
Sabinsa Japan, based in Tokyo Metro � Japan, will be featuring a number of new beverage concepts and also present a seminar on new products at IFIA Japan 2002 May 08 to 20, 2022 at Tokyo Big Sight West Hall. The trade show, organized by Food Chemical Newspaper Inc, is expected to attract over 30,000 visitors.…
Read MoreSabinsa to Showcase Innovative, Clinically Studied Ingredients at VitaFoods Europe
Sabinsa Corporation, the official curcumin sponsor of VitaFoods Europe, will showcase its innovative products at the event in Geneva, Switzerland 10 - 12 May, 2022, in addition to presenting a scientific mini-seminar for their customers.…
Read MoreSabinsa Participates in Science Event Honoring the 70th Anniversary of Diplomatic Relations Between India and Japan
Mr. Yoshiaki Adachi, Sabinsa�s technical staff in Japan, gave a presentation on Sabinsa�s key ingredients inspired by Ayurveda…
Read MoreSabinsa to Showcase Innovative Hair Care & Skin Care Actives at NYSCC 2022
Sabinsa Corporation, a vertically integrated, research-oriented company known for providing sustainable natural, well researched ingredients for hair and skin care formulations, will be exhibiting at the annual New York Chapter of Society of Cosmetic Chemists event, also known as Suppliers� Day.…
Read MoreSabinsa to Highlight Innovative Ingredients in April at Three Trades Shows: in-cosmetics® Global - 2022 in France, SAPHEX - 2022 in South Africa and SupplySide® EAST in USA
As the nutraceuticals and cosmetics industries begin to gather in person again, Sabinsa�s busy April trade show schedule demonstrates the company�s continued global presence…
Read MoreSabinsa Introduces CurCousin™ Curcumin Analog Ingredient, Health Benefits Include Supporting Healthy Metabolism and Blood Sugar Levels
Sabinsa, the pioneer of ingredients conceived by modern science drawn from traditional Ayurvedic knowledge, has obtained Novel Food approval from the European Food Safety Authority (EFSA)…
Read MoreSabinsa Secures EFSA Novel Food Approval for C3-Reduct�, the Reduced Metabolites of Curcuminoids
Sabinsa, the pioneer of ingredients conceived by modern science drawn from traditional Ayurvedic knowledge, has obtained Novel Food approval from the European Food Safety Authority (EFSA)…
Read MoreSabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
Sabinsa’s intellectual property portfolio now includes 308 separate patents granted across the world. The most recent patents…
Read MoreSabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
Sabinsa has successfully completed the audit for several of its natural cosmetic ingredients as conforming to COSMOS standards…
Read MoreResearch Published on Sabinsa's Curcumin C3 Complex®/BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
Sabinsa's flagship combination product, Curcumin C3 Complex® with BioPerine® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind…
Read MoreCourt Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction For Discovery Abuses in Litigation
Sami-Sabinsa Group Limited, the world leader in Curcumin for the dietary supplements industry, has been awarded more than $1 Million in attorney’s fees and costs against Prakruti Products…
Read MoreSabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
Dr. Muhammed Majeed, founder of the Sami-Sabinsa Group, was named the Father of Indian Nutraceuticals Industry with an honorary award presented on the occasion of ASSOCHAM…
Read MoreNew Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct®…
Read MoreSabinsa Top Scientist Gives Presentation to U.S. FDA
Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA…
Read MoreSabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
Sabinsa ends the year with more good news about achievements. The Confederation of Indian Industry (CII) recognized the Sami-Sabinsa Group…
Read MoreSabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
Sabinsa’s proprietary formulation Macumax® was shown to have vision health benefits in a clinical trial on subjects diagnosed…
Read MoreSabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award…
Read MoreSabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata…
Read MoreSabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
Sabinsa, a pioneer in the nutraceutical and cosmeceutical industry, has provided documentation to appropriate government…
Read MoreSabinsa Providing Glyphosate Test Results with Ingredients
Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, is offering glyphosate test results to customers…
Read MoreSabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
Sabinsa, a pioneer in the nutraceutical and cosmeceutical industries, has expanded its large portfolio of intellectual property…
Read MoreSabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents…
Read MoreDr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
Disruptions from the COVID-19 pandemic have caused hardship across the world, with the poorest people in India hit particularly hard …
Read MoreSabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property …
Read MoreSabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning…
Read MoreResearch on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits Among the First Published Human Clinical Studies Examining a Probiotic Metabolite
As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge…
Read MoreSabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
Sabinsa has sent a cease & desist letter to Applied Food Sciences (AFS) for making claims of high levels of natural vitamin C in that company’s branded amla (Emblica officinalis) extract...…
Read MoreSabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces…
Read MoreSabinsa Earns Non-GMO Project Verification for Eleven Key Ingredients
Sabinsa is pleased to announce that several of the company’s ingredients have been N…
Read MoreSabinsa’s Curcumin C3 Complex® with BioPerine® Shown to Improve Cytokine Level
Sabinsa’s Curcumin C3 Complex®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine®, on serum cytokine…
Read MoreDr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
Sabinsa founder and chairman Dr. Muhammed Majeed presents check to PM CARES Fund…
Read MoreSabinsa Warns Industry Against Mischaracterized Amla Extracts
Material Claiming Naturally High Amounts of Vitamin C IRMS-Tested, Establishing It as Non-Amla, Fermentation Source…
Read MoreResearch Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
In these uncertain days of the highly contagious coronavirus, the absence of pharmaceutical intervention in the form of…
Read MoreSabinsa's pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
Two new studies have recently been published on the topical benefits of Sabinsa’s pTeroWhite® natural pteros…
Read MoreSami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
Sami-Sabinsa Group, a pioneer and global leader in health science, was honored with three awards by the Associated Cham…
Read MoreSabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
Shaheen Majeed, President Worldwide, to speak about sustainability
Sabinsa will demon…
Read MoreSabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
Sami-Sabinsa Group hosted a ground-breaking ceremony, on January 20, 2020, for a new Active Pharmaceutical Ingredients …
Read More